BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 29, 2010
View Archived Issues
'Peer Esteem' is Key Factor in Predicting Nobel Winners
Read More
Newco News: Excelimmune Aims Polyclonal Antibodies at Bacterial Disease
Read More
Researcher's Pet Project Leads to Eye Therapy, Lasker Prize
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Prostate Cancer Takes Hit with Pfizer, AstraZeneca Failures
The prostate cancer therapy arena was dealt two blows this week, with Pfizer Inc.'s Sutent (sunitinib malate) and AstraZeneca plc's zibotentan both failing to demonstrate an improvement in overall survival. (BioWorld Today)
Read More
Sanofi-Aventis Grabs Pieris' Protein Therapy Platform
Read More
Financings Roundup
Read More